The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Peritoneal Cancer Market Research Report 2024
Synopsis
Peritoneal cancer is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma and psammomacarcinoma.
The global Peritoneal Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Peritoneal cancer develops in a thin layer of tissue that lines the abdomen. It also covers the uterus, bladder and rectum.
This report aims to provide a comprehensive presentation of the global market for Peritoneal Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peritoneal Cancer.
Report Scope
The Peritoneal Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peritoneal Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peritoneal Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
GlaxoSmithKline
Oxford BioMedica
Millennium Pharmaceuticals
Novartis
Bayer
Incyte
EntreMed
Oncolytics Biotech
Synta Pharmaceuticals
Oasmia Pharmaceutical
Segment by Type
Surgery
Chemotherapy (Anticancer Drugs)
Radiotherapy (High-Energy Rays)
Segment by Application
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peritoneal Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Peritoneal cancer is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma and psammomacarcinoma.
The global Peritoneal Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Peritoneal cancer develops in a thin layer of tissue that lines the abdomen. It also covers the uterus, bladder and rectum.
This report aims to provide a comprehensive presentation of the global market for Peritoneal Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peritoneal Cancer.
Report Scope
The Peritoneal Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peritoneal Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peritoneal Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
GlaxoSmithKline
Oxford BioMedica
Millennium Pharmaceuticals
Novartis
Bayer
Incyte
EntreMed
Oncolytics Biotech
Synta Pharmaceuticals
Oasmia Pharmaceutical
Segment by Type
Surgery
Chemotherapy (Anticancer Drugs)
Radiotherapy (High-Energy Rays)
Segment by Application
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peritoneal Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peritoneal Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgery
1.2.3 Chemotherapy (Anticancer Drugs)
1.2.4 Radiotherapy (High-Energy Rays)
1.3 Market by Application
1.3.1 Global Peritoneal Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer Research Centers
1.3.3 Cancer Hospital
1.3.4 Surgical Centers
1.3.5 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peritoneal Cancer Market Perspective (2019-2030)
2.2 Peritoneal Cancer Growth Trends by Region
2.2.1 Global Peritoneal Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peritoneal Cancer Historic Market Size by Region (2019-2024)
2.2.3 Peritoneal Cancer Forecasted Market Size by Region (2025-2030)
2.3 Peritoneal Cancer Market Dynamics
2.3.1 Peritoneal Cancer Industry Trends
2.3.2 Peritoneal Cancer Market Drivers
2.3.3 Peritoneal Cancer Market Challenges
2.3.4 Peritoneal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peritoneal Cancer Players by Revenue
3.1.1 Global Top Peritoneal Cancer Players by Revenue (2019-2024)
3.1.2 Global Peritoneal Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Peritoneal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peritoneal Cancer Revenue
3.4 Global Peritoneal Cancer Market Concentration Ratio
3.4.1 Global Peritoneal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peritoneal Cancer Revenue in 2023
3.5 Peritoneal Cancer Key Players Head office and Area Served
3.6 Key Players Peritoneal Cancer Product Solution and Service
3.7 Date of Enter into Peritoneal Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peritoneal Cancer Breakdown Data by Type
4.1 Global Peritoneal Cancer Historic Market Size by Type (2019-2024)
4.2 Global Peritoneal Cancer Forecasted Market Size by Type (2025-2030)
5 Peritoneal Cancer Breakdown Data by Application
5.1 Global Peritoneal Cancer Historic Market Size by Application (2019-2024)
5.2 Global Peritoneal Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Peritoneal Cancer Market Size (2019-2030)
6.2 North America Peritoneal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Peritoneal Cancer Market Size by Country (2019-2024)
6.4 North America Peritoneal Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peritoneal Cancer Market Size (2019-2030)
7.2 Europe Peritoneal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Peritoneal Cancer Market Size by Country (2019-2024)
7.4 Europe Peritoneal Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peritoneal Cancer Market Size (2019-2030)
8.2 Asia-Pacific Peritoneal Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Peritoneal Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Peritoneal Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peritoneal Cancer Market Size (2019-2030)
9.2 Latin America Peritoneal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Peritoneal Cancer Market Size by Country (2019-2024)
9.4 Latin America Peritoneal Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peritoneal Cancer Market Size (2019-2030)
10.2 Middle East & Africa Peritoneal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Peritoneal Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Peritoneal Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Peritoneal Cancer Introduction
11.1.4 AstraZeneca Revenue in Peritoneal Cancer Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Peritoneal Cancer Introduction
11.2.4 GlaxoSmithKline Revenue in Peritoneal Cancer Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Peritoneal Cancer Introduction
11.3.4 Oxford BioMedica Revenue in Peritoneal Cancer Business (2019-2024)
11.3.5 Oxford BioMedica Recent Development
11.4 Millennium Pharmaceuticals
11.4.1 Millennium Pharmaceuticals Company Detail
11.4.2 Millennium Pharmaceuticals Business Overview
11.4.3 Millennium Pharmaceuticals Peritoneal Cancer Introduction
11.4.4 Millennium Pharmaceuticals Revenue in Peritoneal Cancer Business (2019-2024)
11.4.5 Millennium Pharmaceuticals Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Peritoneal Cancer Introduction
11.5.4 Novartis Revenue in Peritoneal Cancer Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Peritoneal Cancer Introduction
11.6.4 Bayer Revenue in Peritoneal Cancer Business (2019-2024)
11.6.5 Bayer Recent Development
11.7 Incyte
11.7.1 Incyte Company Detail
11.7.2 Incyte Business Overview
11.7.3 Incyte Peritoneal Cancer Introduction
11.7.4 Incyte Revenue in Peritoneal Cancer Business (2019-2024)
11.7.5 Incyte Recent Development
11.8 EntreMed
11.8.1 EntreMed Company Detail
11.8.2 EntreMed Business Overview
11.8.3 EntreMed Peritoneal Cancer Introduction
11.8.4 EntreMed Revenue in Peritoneal Cancer Business (2019-2024)
11.8.5 EntreMed Recent Development
11.9 Oncolytics Biotech
11.9.1 Oncolytics Biotech Company Detail
11.9.2 Oncolytics Biotech Business Overview
11.9.3 Oncolytics Biotech Peritoneal Cancer Introduction
11.9.4 Oncolytics Biotech Revenue in Peritoneal Cancer Business (2019-2024)
11.9.5 Oncolytics Biotech Recent Development
11.10 Synta Pharmaceuticals
11.10.1 Synta Pharmaceuticals Company Detail
11.10.2 Synta Pharmaceuticals Business Overview
11.10.3 Synta Pharmaceuticals Peritoneal Cancer Introduction
11.10.4 Synta Pharmaceuticals Revenue in Peritoneal Cancer Business (2019-2024)
11.10.5 Synta Pharmaceuticals Recent Development
11.11 Oasmia Pharmaceutical
11.11.1 Oasmia Pharmaceutical Company Detail
11.11.2 Oasmia Pharmaceutical Business Overview
11.11.3 Oasmia Pharmaceutical Peritoneal Cancer Introduction
11.11.4 Oasmia Pharmaceutical Revenue in Peritoneal Cancer Business (2019-2024)
11.11.5 Oasmia Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
